chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After I was vaccinated, I didn't have any initial symptoms and then about thirty minutes after my right shoulder was throbbing and I felt very dizzy. An EMT that was at the vaccination site checked my BP and pulse and monitored me and suggested I go home and rest. She said not to take Tylenol unless I absolutely needed it. When I got home I felt absolutely tired and exhausted. By 6:00PM I was developing a low grade fever. I went to the ER at 5/29/2021 at 7:00PM. My temp was 101.5 so I went and got checked out at the ER. The diagnosis was elevated procalcitonin and they ordered a number of labs as well. They also said it was a post vaccination reaction. They gave me about a 1,000 MG of Tylenol and a liter of fluids. I was at the ER for about 3 hours. I also had swelling and rash around the injection site, a raised rash which almost looked like a burn to me it was about 3 inches. I felt tired and weak for about a week to so following this. Another thing that started was vertigo and migraines, but I was suspected of having Covid twice so DRs do not know and it is hard to sat what that is in regards to. I may have had Covid in March 2020 and Feb 2021, I was unable to get tested but the first time it lasted about 6 weeks and the second time was more mild.
Mild headache, mild nausea, chills, diarrhea and fatigue--lasted 1 day
Within five minutes from receiving vaccine, patient reported feeling lightheaded, nauseous, and was pale. He was offered water and blood pressure was taken around 7:10pm, showing 61/43 mmHg. Upon patient's mother's consent, emergency services was called where he had his vitals re-checked. After ten minutes, his vitals are normal and blood pressure was back up to normal range. Patient was able to stand without dizziness. His mother was given the option to go to the hospital for further monitoring or leave on their own, in which she decided they were to leave on their own and monitor at home.
Information has been received from a registered nurse concerning a 23 year old female who faints easily and with a history of seizures after car accident in 2004, and issues with a shot given in the past, but unknown what drug or vaccine, or unknown what type of reaction who on 23-SEP-2008 was vaccinated with the first dose of GARDASIL (Lot # 661044/0548X), 0.5 ml, intramuscularly, into the left deltoid. There was no concomitant medication. The registered nurse reported that 5 minutes post vaccination the patient experienced an adverse event. The nurse reported that the patient said that she did not feel good. The patient had seizure activity, some shaking, her eyes rolled back into her head, she passed out, and had loss of urine. When the client came to she experienced nausea and vomiting. Her pulse was weak, but her airway was open. The nurse reported that the patient was given oral fluids, crackers and was monitored. One hour later the patient's blood pressure was 110/72. Prior to administering the GARDASIL vaccine a unsuccessful blood draw was attempted on client, but after vaccination another blood drawn was taken. A cat scan was performed with negative results. At the time of the report a EEG was scheduled. The patient sought medical attention at internist office. At the time of the report the registered nurse called the patient and she said that she was "tired but was feeling much better today". Upon internal review, seizure was considered to be an other important medical event. Additional information is expected.
Patient received her pfizer booster.  The next day she began to experience itching on the left side of her face.  Then she developed numbness and tingling on the left side of her face .  She went to ER and had mri of her brain which was normal.  I saw her in follow up.  she has continued to experience constant numbness on the left side of her face.    She reported that she will get a random occasional more painful "zing" in the same area.
Contracted/Tested positive for covid19 after receiving 1st dose of vaccine..*1st dose was 1/22/21 **Tested positive 2/4/21**2nd dose 2/12/21; After second dose, I had rash, discoloration along left leg and painful swelling in left axillary area for 3 days, bad headache, felt ill(chills).
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.
No additional AE information provided; PROQUAD was administered to a patient on 12/13/2022 after a supported temperature excursion that took place on 12/1/2022.; This spontaneous report was received from a medical assistant referring to a patient of unknown gender and age. The patient's medical histories, concomitant medications, concurrent conditions and drug reaction/allergies were not reported.  On 13-DEC-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (0.5 milliliters, lot #W020552, expiration date: 26-DEC-2023, recombinant Human albumin [rHA] ) administrated for prophylaxis (strength, route of administration and anatomical site of administration were not provided), which supported temperature excursion occurred on 01-DEC-2022, the temperature was reported as 19.47 degree Fahrenheit (F) for 50 minutes (product storage error). The temperature excursion was not occurred previously. No additional adverse event  information was provided (no adverse event).
pt recv 2 doses of vax & approx 3 wk p/vax pt devel less than 50 lesions;lab eval 6-7 wk p/vax revealed an equivocal titer;
Narrative: 96M with past medical history of DM, HTN, HLD, protein C deficiency with recurrent DVTs on coumadin, and history of squamous cell carcinoma s/p lobectomy presents to Emergency Department on 8/20/2021 with chief complaint of SOB x 2 days ago while he was at his long term care facility. He reported occasional cough that is not productive. He denied chest pain, fever, chills, sweats. He was COVID negative on 8/20/21. He stated that the day prior to admission, he began to feel worse with body aches and fatigue. Denied any recent sick contacts and was afebrile. Pt stated that he is on 3L of O2 as his home oxygen, however, he feels as though he was still getting SOB without exertion. He was admitted to the hospital. On 8/27, patient developed shortness of breath and a rapid response was called, patient was up to on 5L of O2 and was given an extra dose of Lasix 40mg IV. Additionally a bladder scan was performed and showed 500ml, and 350ml of puss filled urine was extracted. Urinalysis was performed and showed cloudy in appearance with many bacteria, and WBC clumps. Later in the morning around 0900, patient had a second rapid response called due to difficulty in arousing patient. His hospital roommate was coughing as well, so COVID test done in this patient and was positive despite being vaccinated with Moderna COVID vaccine on 1/15/2021 and 2/12/2021. Despite IV antibiotics, antifungals and intensive COVID therapies, the patient ultimately passed away 3 days later on 8/30 due to COVID pneumonia.
Mom called stating pt. had local reaction at injection site 10 days after vaccine was administered SC/LT. (See 13-A for lot #).
Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35 F; Doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35 F) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 11:13 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 11:13 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35 F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35 F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  On 12-Feb-2021, excursion time was 9 AM, temperature was 29, 10 AM, temperature was 35 and 11 AM, temperature was 35. Total doses given for the day was 55, condition of vaccine prior to administration was not frozen. The vial was initially moved to the fridge on 09-Feb-2021 and beyond use date was 10-Mar-2021. 3 vials were sent to clinic on 12-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  No treatment medications were reported.
After injection, had some soreness in arm and a small red rash around injection site for about 3-4 days. Then on day 7 (1/17) I noticed the redness coming back from injection site, it was also itchy.  8th day (1/18)  injection site was swollen, red, hot, itchy and much larger about 3in x 3in. I took some Benadryl at night to see if that would help.  On day 9 (1/19) swelling and redness is a little better but still present.
pt recv vax & devel pain @ inj site as well as numbness;no other details were known as of the reporting date;
I was exposed to COVID from someone who was vaccinated. I was sick with body aches, difficulty breathing, coughing, fatigue, fever. I did the nebulizer every 4 hours and increased my Advair dosage to a higher dose. I took Tylenol.
Red rash that began on Day 7 following first dose Moderna vaccination.  Very itchy, sore and stinging.  This spread to cover the entire forearm and lasted approximately 7 days.
has not gotten his second dose, yet; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not gotten his second dose, yet) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not gotten his second dose, yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (has not gotten his second dose, yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Initial and follow-up information has been received from a physician and licensed practitioner nurse (office manager) concerning a 15 year old male patient with no pertinent medical history, concurrent conditions, or drug allergies who on 14-MAY-2010 was vaccinated with the first dose of GARDASIL (lot# 663559/1178Y). There were no concomitant vaccines or therapy. The physician stated that on 14-MAY-2010 the patient experienced facial swelling, similar to Stevens-Johnson syndromes but without the skin reaction, after his first vaccination with GARDASIL. The patient was seen in the Emergency Room where he received IV Benadryl and IV steroids and a MEDROL dose pack for home. The patient was not admitted to the hospital. The physician reported that the patient also had dizziness, headache and insomnia. The office manager reported that the patient had followed-up at the office on 19-MAY-2010. The patient still not totally recovered, but was doing better. The manager confirmed that the event was not Stevens-Johnson syndrome. The event was not considered disabling or life threatening by the office manager. The office was unsure if the next dose in the GARDASIL series would be given. "Facial swelling, dizziness, headache and insomnia" were considered to be other important medical events by the physician. Additional information has been requested.
Tdap administered prior to patient being 11 years old. Plan to get another dose of Tdap.
Local reaction to posterior left forearm, developed erythema, tenderness, and some itching.  2.5 cm circle indurated at site of injection and total 8 cm of erythema.
the patient stated it was painful and then asked for water. After returning with water, it was observed that he was gasping for air and his head tilted back. This turned into a shaking/seizure reaction where he was unable to respond. After around 30-60 seconds, the patient sat back up and immediately reached for the water and asked what happened.
Flu; redness in the right arm; pain in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness in the right arm), INJECTION SITE PAIN (pain in the right arm) and INFLUENZA (Flu) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023MZ0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (redness in the right arm) and INJECTION SITE PAIN (pain in the right arm). On an unknown date, the patient experienced INFLUENZA (Flu). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of 1 dosage form. At the time of the report, INJECTION SITE ERYTHEMA (redness in the right arm), INJECTION SITE PAIN (pain in the right arm) and INFLUENZA (Flu) had resolved.            Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-MAY-2021 outcome updated.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: Unknown. The reporter is the patient. A 76-year-old male patient received BNT162b2 (BNT162B2), on 23Feb2021 as dose 1, single (Lot number: EN6200), in Mar2021 as dose 2, single (Lot number: EN6208) and as dose 3 (booster), single (Lot number: FH8020) for Covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got one booster dose and then he tested positive for Covid- 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: he tested positive for Covid-19. Therapeutic measures were taken as a result of drug ineffective, Covid-19. Clinical Course: Receiving the primary series of the Pfizer BioNTech Covid-19 vaccine and a Pfizer-BioNTech Covid-19 booster and then getting a mild case COVID-19 disease. He was prescribed Paxlovid as treatment and is currently taking Paxlovid. He received the Pfizer Covid-19 Vaccine and he got his series and also got one booster dose and then he tested positive for Covid-19. LOT# (Paxlovid): PAA183761. Anatomical Site: Consumer stated, "Probably his left arm but he was not sure".
approximately 6 days after immunization patient developed a red warm nodule at injection site that over 2 days became more tender, firm and larger
Breakthrough case. Vaccinated 1/13/2022, tested positive on 07/04/2022. Started feeling really exhausted and sinus's were more severe. Haven't fully recovered.
Swelling of (Rt) and (Lt) arms, vomiting at 3-4 am the night after (5/30/12 am). Arms are red around injection sites.
This case was reported by a nurse and described the occurrence of an injection site reaction in a 55 year old female pt who received Twinrix. The pt's medical history was notable for hepatitis C positivity. Concurrent medications included Nifedipine to treat hepatitis C. On 4/25/05, the pt received the first dose of Twinrix in the right arm (lot AHAVBA015BA). The nurse reported that, "at time of vaccination", on 4/25/05, "the pt had just finished exercising and muscles were stiff". "The nurse stated that, "as soon as needle was pulled out, "the pt experienced an injection site reaction characterized as bleeding and swelling. The nurse stated that, "the arm is swollen around the injection site-about the size of a half dollar." The injection site reaction was ongoing at the time of initial reporting, 4/25/05.
Day 12 Itching, warm to touch and red, ringed rash around injections site. Previous reactions on day 2 subsided about day 7.
hot; reaction that she had 17 days after getting the first vaccine; red area that is 3 inches wide and 6 inches long; swollen; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot), VACCINATION SITE REACTION (reaction that she had 17 days after getting the first vaccine), VACCINATION SITE ERYTHEMA (red area that is 3 inches wide and 6 inches long) and VACCINATION SITE SWELLING (swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced FEELING HOT (hot), VACCINATION SITE REACTION (reaction that she had 17 days after getting the first vaccine), VACCINATION SITE ERYTHEMA (red area that is 3 inches wide and 6 inches long) and VACCINATION SITE SWELLING (swollen). At the time of the report, FEELING HOT (hot), VACCINATION SITE REACTION (reaction that she had 17 days after getting the first vaccine), VACCINATION SITE ERYTHEMA (red area that is 3 inches wide and 6 inches long) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information and concomitant medications were reported.
Patient was given compromised (frozen) FLUZONE .25 ml prefilled syringe pediatric dose.
Patient experienced soreness in arm and tingling in hand. Patienr reported to doctor who said it was most likely from shot and should go away.
Information has been received from a pharmacist concerning her approximately 15 year old daughter with no known allergies and no reported medical history who was vaccinated with Gardasil.  There was no concomitant medication.  The pharmacist reported that her daughter developed muscle pain near the injection site after her last two doses of Gardasil.  The symptoms resolved several days after each dose was given.  She had not received dose number three yet.  Additional information has been requested.
Constant headache has lasted for the entire week,   Very small windows of relief but headaches persist. Tylenol helps but doesn?t get rid of headache. Mostly back of the head and left side of the head.
Severe non-stop heart palpitations for 3-4 weeks, extreme fatigue, shortness of breath, complete loss of appetite, weight loss over 10 lbs. Severe abdominal pain on Apr 23rd.  Neurological symptoms such as eye twitching. Burning sensation in throat and gut. Three ER visits between April 20 and May 4th.   Extreme fatigue and and have had to take off from work and studies for over 2 months. Following up with neurologist for diagnosis.  I have taken a second shot on June 14th, J&J vaccine.
Pt had syncopal episode after GARDASIL.  Did not fall, guided to chair by me & aroused with ammonia & cold wet cloth.  No seizure act.  Pulse always present.  Given water & granola bars